Infants are qualified for this study if they are 0 to 3 months of age at time of enrollment.
Infants must have been delivered via Cesarean delivery (C-section), either scheduled or emergent.
Infants must have been at least 36 weeks gestation at time of delivery.
Infants and their caregivers must reside in the United States with a US mailing address.
You may not be if
Infants can not have been given probiotic supplements in their life at recruitment. This includes probiotic powder or supplements or formula with probiotic addition or multivitamin with probiotic addition.
Twin and multiple birth infants are not accepted in this study.
Infants cannot have the following existing health conditions:
Gastrointestinal conditions: Hirschsprung disease, eosinophilic gastrointestinal disorders (EGID) including eosinophilic esophagitis (EoE), necrotizing enterocolitis (NEC), short bowel syndrome (SBS)
Immune or auto-immune conditions: Severe Combined Immunodeficiency (SCID), human immunodeficiency virus (HIV)), excluding eczema and rashes
Congenital conditions: cleft lip or cleft palate, congenital heart disease, cerebral palsy, fragile X syndrome, down syndrome, spina bifida, cystic fibrosis, phenylketonuria (PKU), congenital hypothyroidism (CHT), galactosaemia)
Infant or any immediate family member has previously received results from an at-home microbiome stool test (excluding standard clinical diagnostic testing such as stool culture or pathogen testing)
Clareo Health | Flourish: Exploring the Early Infant Gut Microbiome
